Cargando…

Drug Use Evaluation of Endocrine Therapy in Women with Breast Cancer in a Chinese Hospital

Prescription drugs constitute an important component of health care. However, drugs can benefit patients only if they are used appropriately. Drug use evaluation (DUE) can detect inappropriate and/or unnecessarily costly drug therapy and thereby promote the rational use of drugs. Because DUE program...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yanni, Wang, Li, Lu, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2011
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437636/ https://www.ncbi.nlm.nih.gov/pubmed/21787034 http://dx.doi.org/10.18553/jmcp.2011.17.6.481

Ejemplares similares

Description of Major Osteoporotic Fractures in Women with Invasive Breast Cancer Who Received Endocrine Therapy
por: Lo, Joan C., et al.
Publicado: (2021)

The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer
por: Kang, Yi-Kun, et al.
Publicado: (2021)

Primary Endocrine Therapy in Older Women with Breast Cancer
por: Pepping, R. M. C., et al.
Publicado: (2017)

Association of Endocrine Therapy and Dementia in Women with Breast Cancer
por: Thompson, Mikayla R, et al.
Publicado: (2021)

Association of Endocrine Therapy With Overall Survival in Women With Small, Hormone Receptor–Positive, ERBB2-Negative Breast Cancer
por: Ma, Sung Jun, et al.
Publicado: (2020)

Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women
por: Pritchard, Kathleen
Publicado: (2005)

Adjuvant endocrine therapy for premenopausal women with early breast cancer
por: Bao, Ting, et al.
Publicado: (2007)

Self-Reported Adherence to Oral Endocrine Therapy among Breast Cancer Patients in Jordan
por: Faqeer, Nour, et al.
Publicado: (2022)

Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer
por: Rillamas-Sun, Eileen, et al.
Publicado: (2023)

Early breast cancer in elderly women: surgery or primary endocrine therapy?
por: Rocco, N, et al.
Publicado: (2010)

Yoga: An endocrine therapy
por: Kaduskar, Prashant, et al.
Publicado: (2015)

Preventing invasive breast cancer using endocrine therapy
por: Thorat, Mangesh A., et al.
Publicado: (2017)

Pharmacogenomics of endocrine therapy in breast cancer
por: Ingle, James N
Publicado: (2013)

Beliefs about medicines and adherence in women with breast cancer on adjuvant endocrine therapy
por: Tan, Eng Hooi, et al.
Publicado: (2021)

Evidence on Efficacy and Safety of Chinese Medicines Combined Western Medicines Treatment for Breast Cancer With Endocrine Therapy
por: Li, Lu, et al.
Publicado: (2021)

Association of Adherence to Endocrine Therapy Among Patients With Breast Cancer and Potential Drug-Drug Interactions
por: Rassy, Elie, et al.
Publicado: (2022)

Adherence status to Adjuvant Endocrine Therapy in Chinese Women with Early Breast Cancer and its influencing factors: A cross‐sectional survey
por: Xu, Hui, et al.
Publicado: (2020)

Adherence to endocrine therapy among Chinese patients with breast cancer: current status and recommendations for improvement
por: Gao, Pin, et al.
Publicado: (2018)

Cognitive function among women with breast cancer receiving endocrine therapy: what are the impacts?
por: Fardell, Joanna E, et al.
Publicado: (2023)

Status of adjuvant endocrine therapy for breast cancer
por: Schiavon, Gaia, et al.
Publicado: (2014)

Pathways to Endocrine Therapy Resistance in Breast Cancer
por: Haque, Md. Moquitul, et al.
Publicado: (2019)

The immunomodulatory effects of endocrine therapy in breast cancer
por: Huang, Huanhuan, et al.
Publicado: (2021)

Updates in endocrine therapy for metastatic breast cancer
por: Manohar, Poorni M., et al.
Publicado: (2022)

Clinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2− Metastatic Breast Cancer
por: Song, Yan, et al.
Publicado: (2015)

Patient-derived scaffolds as a drug-testing platform for endocrine therapies in breast cancer
por: Gustafsson, Anna, et al.
Publicado: (2021)

Approaches to interpret the outcomes of a network meta-analysis on comparative efficacy of different targeted therapies plus fulvestrant for advanced breast cancer following progression on prior endocrine therapy
por: Jayaraj, Rama, et al.
Publicado: (2019)

Comparison of changes in lipid profiles of premenopausal women with early-stage breast cancer treated with different endocrine therapies
por: Wang, Kaiyue, et al.
Publicado: (2022)

Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors
por: Matthews, Anthony A, et al.
Publicado: (2021)

Women’s coping strategies during the first three months of adjuvant endocrine therapy for breast cancer
por: Ahlstedt Karlsson, Susanne, et al.
Publicado: (2019)

Factors associated with initiation and continuation of endocrine therapy in women with hormone receptor-positive breast cancer
por: Cho, Beomyoung, et al.
Publicado: (2022)

Association of Endocrine Therapy Initiation Timeliness With Adherence and Continuation in Low-Income Women With Breast Cancer
por: Sood, Nikita, et al.
Publicado: (2022)

Review of bone health in women with estrogen receptor–positive breast cancer receiving endocrine therapy
por: Malagrinò, Matteo, et al.
Publicado: (2023)

Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer
por: Abdel-Razeq, Hikmat
Publicado: (2016)

In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy
por: Cheng, Gary J., et al.
Publicado: (2022)

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease
por: Goldhirsch, Aron, et al.
Publicado: (2015)

Elastosis and response to endocrine therapy in human breast cancer.
por: Masters, J. R., et al.
Publicado: (1979)

A quiet revolution in the endocrine therapy of breast cancer
por: Craig Jordan, V
Publicado: (2003)

Predicting response/resistance to endocrine therapy for breast cancer
por: Miller, WR, et al.
Publicado: (2005)

Metastatic breast cancer: Endocrine therapy landscape reshaped
por: Salkeni, Mohamad Adham, et al.
Publicado: (2017)

Novel Strategies to Improve the Endocrine Therapy of Breast Cancer
por: Castrellon, Aurelio Bartolome
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gtq9mnuabfab02r9tgal50q5be